Wealth Dimensions Group, Ltd. Astrazeneca PLC Transaction History
Wealth Dimensions Group, Ltd.
- $394 Million
- Q3 2024
A detailed history of Wealth Dimensions Group, Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Wealth Dimensions Group, Ltd. holds 5,395 shares of AZN stock, worth $367,939. This represents 0.11% of its overall portfolio holdings.
Number of Shares
5,395
Previous 5,576
3.25%
Holding current value
$367,939
Previous $434,000
3.23%
% of portfolio
0.11%
Previous 0.12%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,345Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.29 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.86 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.54 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.51 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.3 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...